| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-30 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-09-02 |
|---|---|---|---|
| Revenue (Total Sales) | $3.77B | $3.82B | $4.01B |
| YoY Revenue Growth % | -1.3% | -4.7% | — |
| Gross Profit | $1.54B | $1.57B | — |
| Gross Margin % | 40.8% | 41.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $301.6M | $390.4M | $483.7M |
| Operating Margin % | 8.0% | 10.2% | 12.1% |
| Net Income (GAAP) | $199.3M | $258.6M | $343.2M |
| EBITDA (Normalized) | $375.8M | $469.9M | $628.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $333.7M | $410.7M | $699.6M |
| Capital Expenditures (CapEx) | $92.8M | $99.4M | $180.4M |
| Free Cash Flow (FCF) | $240.9M | $311.3M | $519.2M |
| FCF Margin % | 6.4% | 8.1% | 12.9% |
| Return on Invested Capital (ROIC %) | 13.0% | 17.1% | 13.2% |
| Cash & Short-Term Equivalents | $40.3M | $57.3M | — |
| Total Debt (Short + Long Term) | $496.9M | $490.6M | $1.13B |
| Total Stockholders' Equity | $1.38B | $1.38B | $2.31B |